• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CLVS

CLVS

Clovis Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.08

+0.00 (+0.00%)

Company Profile

CEO

Patrick Mahaffy

IPO Date

2011-11-16

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.08

Prev. Close

$0.08

Day Low

$0.08

Day High

$0.10

52W Low

$0.04

52W High

$3.25

Volume

24.21M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

36.0%

Avg Negative

15.0%

Avg Neutral

49.1%

News Feed

Why Clovis Oncology Shares Got a Bump This Week

The Motley Fool·8/27/2021·↑ positive

Clovis Oncology Announces Availability of and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Switzerland

Business Wire·8/24/2021·↑ positive

Clovis Oncology Announces Renewal of At-The-Market Equity Offering Program

Business Wire
·8/16/2021
·↑ positive

Clovis: Compelling With Upcoming Catalysts

Seeking Alpha·7/29/2021·↑ positive

Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors

Business Wire·7/12/2021·↑ positive

What's Going On With Clovis Oncology Stock?

Benzinga·7/12/2021·↓ negative

Here's Why Wall Street Is Betting Against Clovis Oncology

The Motley Fool·6/12/2021·↑ positive

Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders

Business Wire·6/10/2021·↓ negative

CLVS Stock: Is a Reddit-Fueled Short Squeeze Brewing for Clovis Oncology?

InvestorPlace·6/9/2021·↓ negative

Clovis (CLVS) Down 5.3% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research·6/4/2021·↓ negative